High-risk neuroblastoma

Pediatric Oncology The Impact of COG versus Rapid COJEC Chemotherapy on Survival Following Autograft for High-Risk Neuroblastoma: A Ten-Year Retrospective Study from a Tertiary Referral Centre from Southern India
Seshadri Nithya • Minakshi Balwani • Anuraag R Nalla • Kavitha Ganesan • Ramya Uppuluri • Revathi Raj
doi.org/10.69690/ODMJ-018-0425-2839
Pediatric Oncology Central Nervous System Recurrence (Isolated/Multi-site) in Patient With HR NBL: Incidence, Clinical feature and Outcome in the Post Immunotherapy Era Multi-Centre Study, National Guard Hospital Jeddah and Riyadh 2010-2023
Enas Santali • Khalid Abdalla • Abeer Al Mehdar • Manar Abdelkhalek • Naglla Elimam • Naveed Ahmed
doi.org/10.69690/ODMJ-018-0425-2006
Pediatric Oncology Treatment Outcomes in High-Risk Neuroblastoma in Children Treated with Dinutuximab Beta: A 15-Year Retrospective Single-Center Study Experience
Sameh Awwad • Mohammad Rayis • Zaheer Ullah Khan
doi.org/10.69690/ODMJ-018-0425-908
Pediatric Oncology Local Control with 21 vs 36 Gy radiation Therapy of the Primary Tumor Bed for High-Risk Neuroblastoma
Anastasia Usychkina • Tatyana Shamanskaya • Denis Kachanov • Mikhail Strozhenkov • Anna Loginova • Yuliya Voevodina • Alexey Nechesnyuk
doi.org/10.69690/ODMJ-018-0425-1068